EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND ASSOCIATED MALIGNANT TUMORS (REVIEW OF LITERATURE)

E. V Lipova; G. N Tarasenko; N. V Gryazeva

doi:10.17816/dv36709

Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (3) :51 -55. DOI: 10.17816/dv36709

Articles

review-article

EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND ASSOCIATED MALIGNANT TUMORS (REVIEW OF LITERATURE)

Author information +

History +

PDF

Abstract

The epidemiology of cervical cancer and anogenital warts in Europe, America. and Russia and programs for prevention of and screening for human papillomavirus all over the world are reviewed.

Keywords

HPV / cervical cancer / anogenital warts / epidemiology / incidence rates / vaccination / screening

Cite this article

Download citation ▾

E. V Lipova, G. N Tarasenko, N. V Gryazeva. EPIDEMIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND ASSOCIATED MALIGNANT TUMORS (REVIEW OF LITERATURE). Russian Journal of Skin and Venereal Diseases, 2012, 15(3): 51-55 DOI:10.17816/dv36709

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Коломиец Л.А. // Медицинская газета. — 2011. — № 58. — С. 4

[2]	Рыбакова Е.Ю. // Особенности эпидемиологии аногенитального герпеса и аногенитальных бородавок и совершенствование системы эпидемиологического надзора за данными инфекциями в условиях крупного мегаполиса: Автореф. дис. ... канд. мед. наук. — М.; 2007.

[3]	Anorlu R. Cervical Cancer: Prevention and Treatment in Sub-Saharan Africa. The 27th International Papillomavirus Conference, 17—22 Sept., 2011, Germany. — Berlin; 2011.

[4]	Brotherton J.M., Fridman M., May C.L. et al. // Lancet. — 2011. — Vol. 377, N 9783. — P. 2085—2092.

[5]	Clifford G., Franceschi S., Diaz M. et al. // Vaccine. — 2006. — Vol. 24, suppl. 3. — P. 26—34.

[6]	Donovan B., Franklin N., Guy R. et al. // Lancet Infect Dis. — 2011. — Vol. 11, N1. — P. 39—44.

[7]	de Sanjose S., Quint W.G., Alemany L. et al.; Retrospective International Survey and HPV Time Trends Study Group // Lancet Oncol. — 2010. — Vol.11, N 11. — P. 1048—1056.

[8]	Ferlay J. et al. // GLOBOCAN. — 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase N10. Lyon, France: International Agency for Research on Cancer. — 2010.

[9]	Garland S M. Cervical Cancer and other HPV-related diseases: Asia Oceania perspective // The 27th International Papillomavirus Conference, 17—22 September, 2011, Germany. — Berlin; 2011.

[10]	Gertig D.M., Brotherton J.M., Saville M. // Sex. Hlth. — 2011. — Vol. 8, N2. — P. 171—178.

[11]	Global and regional profiles immunization profiles // WHO vaccine-preventable diseases monitoring system. — 2010. Global Summary. www.who.int.

[12]	Giuliano A.R. Prevention of Invasive Cervical Cancer in US: Past, Present and Future, PhD. // The 27th International Papillomavirus Conference, 17—22 September, 2011, Germany. — Berlin; 2011.

[13]	Kesic V. Current Status and Perspective of HPV related diseases, screening and vaccination // The 27th International Papillomavirus Conference, 17—22 September, 2011, Germany. — Berlin; 2011.

[14]	Kleter B., van Doorn L.J., Schrauwen L. et al. // J. Clin. Microbiol. — 1999. — Vol. 37, N8. — P 2508—2517.

[15]	Kulmala S.M., Shabalova I.P., Petrovitchev N. et al. // J. Med. Virol. — 2007. — Vol. 79, N6. — P. 771—781.

[16]	Murillo R., Almonte M., Pereira A. et al. // Vaccine. — 2008. — Vol. 26, suppl. 11. — P. 37—48.

[17]	Villa L. Why many Latin-American Women continue to die of cervical cancer // The 27th International Papillomavirus Conference, 17—22 September, 2011, Germany. — Berlin; 2011.